RBMO Shares New Findings on Cell Number Biopsied During PGT-A
Reproductive BioMedicine Online (RBMO) shared a post on LinkedIn:
“This study investigates the effect on diagnostic and clinical outcomes of the number of trophectoderm cells biopsied during blastocyst-stage PGT-A.
The findings suggest that the diagnostic failure rate may be comparable regardless of the number of cells biopsied, after adjustment for potential confounders in multivariable analyses. Minimizing the number of cells biopsied may reduce embryo injury, supporting the need for standardized biopsy protocols that consider both diagnostic yield and embryo preservation.
The authors say their findings emphasize the need for standardized, evidence-based biopsy protocols that consider both diagnostic yield and embryo preservation.
RBMO subscribers can read the full paper from our in-press articles section now.”
Title: Impact of the number of trophectoderm cells biopsied on the quality of preimplantation genetic testing for aneuploidy
Authors: Chiao-Hsin Kung, Che-Min Chen, Ni-Chin Tsai, Yu-Ting Su, Yu-Ju Lin, Fu-Tsai Kung, Kuo-Chung Lan

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 29, 2026, 15:04Proud to Spotlight Dr. Jannie Michielsen and the Expertise She Brings to Every Day – Sims IVF
-
Oct 29, 2026, 14:59Jodi Neuhauser: We Need a Graveyard of Women’s Health Companies (In a Positive Way)
-
Oct 29, 2026, 14:56Resa Nabor: An Inspiring Story of Strength, Courage, and Never Giving Up
-
Oct 29, 2026, 14:54Robert Borowczyk: What Happens After a Failed IVF Cycle?
-
Oct 28, 2026, 15:55Katy Encalade: What Are the Biggest Myths About Egg Donation?
-
Oct 28, 2026, 15:53Diana Kayal: A Free Webinar on Trauma, Infertility and the Patient Journey
-
Oct 28, 2026, 15:49Rebecca Watson O’Connor: Applications for the 2027 PRIMED Cohort Are Open
-
Oct 28, 2026, 15:45Martin Varsavsky: Gameto Has Been Acquired by Ferring for 1.38 Billion Dollars
-
Oct 28, 2026, 15:37Gili Band: The People Are What Stay With Me After Day 1 at ASRM 2026
